CIK 0001080014 · Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943265960
- Phone
- 6502389600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-05-03 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +261,299 | $25.60 | $6.7M | 6,163,577 |
| 2011-02-18 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +152,278 | $23.70 | $3.6M | 5,902,278 |
| 2010-11-29 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +5,750,000 | $22.50 | $129.4M | 5,750,000 |
| 2004-10-08 | GLAXOSMITHKLINE PLC 10% owner | Purchase · Class A common stock | +433,757 | $16.00 | $6.9M | 9,401,498 |
Page 2 of 2 · 24 trades